You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

ribociclib

( rye-boe-SYE-klib )
Funding:
Exceptional Access Program
  • ribociclib - First-line treatment of hormone receptor positive, human epidermal growth factor receptor 2 (HER 2)-negative unresectable locally advanced breast cancer or metastatic breast cancer, with specific criteria
Other Name(s): Kisqali™
Appearance: Tablet.    

Patient Info Sheet

Sep 2019

What it is used for

For treating advanced breast cancer that may not be able to be removed by surgery or has spread to other parts of the body, in combination with another medication



You might also be interested in